Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon https://georgiakbmp965326.aboutyoublog.com/41001810/understanding-semaglutide-a-comprehensive-guide